<?xml version="1.0" encoding="UTF-8"?>
<ref id="B24-antibiotics-10-00092">
 <label>24.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Witherington</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Blaney</surname>
    <given-names>E.L.</given-names>
   </name>
   <name>
    <surname>Bordas</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Elliott</surname>
    <given-names>R.L.</given-names>
   </name>
   <name>
    <surname>Gaiba</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Garton</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Green</surname>
    <given-names>P.M.</given-names>
   </name>
   <name>
    <surname>Naylor</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Smith</surname>
    <given-names>D.G.</given-names>
   </name>
   <name>
    <surname>Spalding</surname>
    <given-names>D.J.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Pyridone derivatives as potent, orally bioavailable VLA-4 integrin antagonists</article-title>
  <source>Bioorg. Med. Chem. Lett.</source>
  <year>2006</year>
  <volume>16</volume>
  <fpage>5538</fpage>
  <lpage>5541</lpage>
  <pub-id pub-id-type="doi">10.1016/j.bmcl.2006.08.044</pub-id>
  <?supplied-pmid 16931004?>
  <pub-id pub-id-type="pmid">16931004</pub-id>
 </element-citation>
</ref>
